Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Vivet Therapeutics closes €37.5mm Series A

Executive Summary

Gene therapy start-up Vivet Therapeutics raised €37.5mm ($40.9mm) through its Series A led by Novartis Venture Fund and Columbus Venture Partners, which were joined by Roche Venture Fund, HealthCap, Kurma Partners, and Ysios Capital.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies